Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Resnick

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.
The New England Journal of Medicine|December 12, 1985
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndromeD D Ho, T R Rota, R T Schooley, et al.
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.
Antiviral Research|April 25, 2000
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teamsG D Morse, R C Reichman, M A Fischl, et al.
Experimental Animals|March 25, 2025
A novel early onset spinocerebellar ataxia 13 BAC mouse model with cerebellar atrophy, tremor, and ataxic gaitJunxiang Yin, Jerelyn A Nick, Swati Khare, et al.
Experientia|December 1, 1992
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843I W Althaus, R J LeMay, A J Gonzales, et al.
The Journal of Biological Chemistry|July 15, 1993
The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, A J Gonzales, J J Chou, et al.
European Radiology|April 22, 2016
Diagnosis of diffuse idiopathic skeletal hyperostosis with chest computed tomography: inter-observer agreementS F Oudkerk, Pim A de Jong, M Attrach, et al.
Genes & Development|October 1, 1992
Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tailC I Brannan, M A Bedell, J L Resnick, et al.
The Journal of Endocrinology|November 2, 2016
Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndromeDavid M Golding, Daniel J Rees, Jennifer R Davies, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.
The New England Journal of Medicine|December 12, 1985
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndromeD D Ho, T R Rota, R T Schooley, et al.
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.
Antiviral Research|April 25, 2000
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teamsG D Morse, R C Reichman, M A Fischl, et al.
Experimental Animals|March 25, 2025
A novel early onset spinocerebellar ataxia 13 BAC mouse model with cerebellar atrophy, tremor, and ataxic gaitJunxiang Yin, Jerelyn A Nick, Swati Khare, et al.
Experientia|December 1, 1992
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843I W Althaus, R J LeMay, A J Gonzales, et al.
The Journal of Biological Chemistry|July 15, 1993
The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, A J Gonzales, J J Chou, et al.
European Radiology|April 22, 2016
Diagnosis of diffuse idiopathic skeletal hyperostosis with chest computed tomography: inter-observer agreementS F Oudkerk, Pim A de Jong, M Attrach, et al.
Genes & Development|October 1, 1992
Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tailC I Brannan, M A Bedell, J L Resnick, et al.
The Journal of Endocrinology|November 2, 2016
Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndromeDavid M Golding, Daniel J Rees, Jennifer R Davies, et al.
Pageof 21